These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21206340)

  • 1. Exercise and fat accumulation in the human liver.
    Magkos F
    Curr Opin Lipidol; 2010 Dec; 21(6):507-17. PubMed ID: 21206340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss.
    Johnson NA; Sachinwalla T; Walton DW; Smith K; Armstrong A; Thompson MW; George J
    Hepatology; 2009 Oct; 50(4):1105-12. PubMed ID: 19637289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pronounced weight loss on visceral fat, liver steatosis and adiponectin isoforms.
    Engl J; Sturm W; Sandhofer A; Kaser S; Tschoner A; Tatarczyk T; Weiss H; Tilg H; Patsch JR; Ebenbichler CF
    Eur J Clin Invest; 2008 Apr; 38(4):238-44. PubMed ID: 18312420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease.
    Kantartzis K; Thamer C; Peter A; Machann J; Schick F; Schraml C; Königsrainer A; Königsrainer I; Kröber S; Niess A; Fritsche A; Häring HU; Stefan N
    Gut; 2009 Sep; 58(9):1281-8. PubMed ID: 19074179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the utility of cardiorespiratory fitness, visceral fat, and liver fat in predicting changes in insulin sensitivity beyond simple changes in body weight after exercise training in adolescents.
    Kuk JL; Lee S
    Appl Physiol Nutr Metab; 2021 Jan; 46(1):55-62. PubMed ID: 32674604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fitness versus fatness: moving beyond weight loss in nonalcoholic fatty liver disease.
    Johnson NA; George J
    Hepatology; 2010 Jul; 52(1):370-81. PubMed ID: 20578153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of alternations (10 days) of high-fat with normal diet on liver lipid infiltration, fat gain, and plasma metabolic profile in rats.
    Lavoie JM; Yasari S; Abdennadher M; Paquette A
    Physiol Behav; 2005 Nov; 86(4):442-8. PubMed ID: 16154606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise and the liver: implications for therapy in fatty liver disorders.
    Johnson NA; Keating SE; George J
    Semin Liver Dis; 2012 Feb; 32(1):65-79. PubMed ID: 22418889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver fat change in obese children after a 1-year nutrition-behavior intervention.
    Pozzato C; Verduci E; Scaglioni S; Radaelli G; Salvioni M; Rovere A; Cornalba G; Riva E; Giovannini M
    J Pediatr Gastroenterol Nutr; 2010 Sep; 51(3):331-5. PubMed ID: 20562718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Has natural selection in human populations produced two types of metabolic syndrome (with and without fatty liver)?
    Caldwell SH; Ikura Y; Iezzoni JC; Liu Z
    J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S11-9. PubMed ID: 17567458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic implications of dietary trans-fatty acids.
    Dorfman SE; Laurent D; Gounarides JS; Li X; Mullarkey TL; Rocheford EC; Sari-Sarraf F; Hirsch EA; Hughes TE; Commerford SR
    Obesity (Silver Spring); 2009 Jun; 17(6):1200-7. PubMed ID: 19584878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocannabinoids and liver disease. IV. Endocannabinoid involvement in obesity and hepatic steatosis.
    Kunos G; Osei-Hyiaman D
    Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1101-4. PubMed ID: 18292184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of weight loss resulting from a combined low-fat diet/exercise regimen on low-density lipoprotein particle size and distribution in obese women.
    Varady KA; Lamarche B; Santosa S; Demonty I; Charest A; Jones PJ
    Metabolism; 2006 Oct; 55(10):1302-7. PubMed ID: 16979399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic strategies in nonalcoholic fatty liver disorders.
    Poordad FF
    Expert Opin Emerg Drugs; 2005 May; 10(2):237-9. PubMed ID: 15934865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body composition and metabolic effects of a diet and exercise weight loss regimen on obese, HIV-infected women.
    Engelson ES; Agin D; Kenya S; Werber-Zion G; Luty B; Albu JB; Kotler DP
    Metabolism; 2006 Oct; 55(10):1327-36. PubMed ID: 16979403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise for weight loss: what are the facts?
    Zelasko CJ
    J Am Diet Assoc; 1995 Dec; 95(12):1414-7. PubMed ID: 7594144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methods for assessing body composition, cardiovascular and metabolic function in children and adolescents: implications for exercise studies.
    Nassis GP; Sidossis LS
    Curr Opin Clin Nutr Metab Care; 2006 Sep; 9(5):560-7. PubMed ID: 16912551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic fatty liver disease as the transducer of hepatic oversecretion of very-low-density lipoprotein-apolipoprotein B-100 in obesity.
    Chan DC; Watts GF; Gan S; Wong AT; Ooi EM; Barrett PH
    Arterioscler Thromb Vasc Biol; 2010 May; 30(5):1043-50. PubMed ID: 20150556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of exercise training on hepatic microsomal triglyceride transfer protein content in rats.
    Chapados NA; Seelaender M; Levy E; Lavoie JM
    Horm Metab Res; 2009 Apr; 41(4):287-93. PubMed ID: 19023847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of Xanthigen in the weight management of obese premenopausal women with non-alcoholic fatty liver disease and normal liver fat.
    Abidov M; Ramazanov Z; Seifulla R; Grachev S
    Diabetes Obes Metab; 2010 Jan; 12(1):72-81. PubMed ID: 19840063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.